Ledger.Open graph →
SEC Form D · Amendment · filed January 24, 2020

Athira Pharma, Inc

Offering
$4.7M
Sold
$3.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

John M. Fluke, Jr · Seattle, WADirectorMark M. Litton · Seattle, WAExecLeen Kawas · Seattle, WAExec · DirectorJoseph W. Harding · Seattle, WADirectorTadataka M. Yamada · Seattle, WADirectorJohn Josey · South San Francisco, CAExecWalter Moos · South San Francisco, CADirectorGregory Alexander · New York, NYExec · DirectorConifer Management, L.L.C · New York, NYDirectorDouglas Stafford · Wauwatosa, WIDirectorHansjoerg M. Moebius · Seattle, WAExecMarc A. Schneebaum · Madison, WIExec · DirectorAndrew E. Ferrara · Madison, WIDirectorWilliam P. Sims · Tomball, TXDirectorTheodore L. Ott · Atlanta, GADirectoran Arizona Limited liability company Camelback Real Estate Equity LLC · Phoenix, AZExecHansjoerg M. Moebius · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗